Provided by Tiger Trade Technology Pte. Ltd.

Biohaven Pharmaceutical Holding Co Ltd.

12.68
-0.1100-0.86%
Volume:1.06M
Turnover:13.80M
Market Cap:1.91B
PE:-2.83
High:13.37
Open:13.03
Low:12.68
Close:12.79
52wk High:18.57
52wk Low:7.48
Shares:150.42M
Float Shares:117.99M
Volume Ratio:0.62
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.4800
EPS(LYR):-6.8648
ROE:-799.46%
ROA:-71.98%
PB:156.05
PE(LYR):-1.85

Loading ...

Oct 06, 2023

Major Issues Report

Form 8-K - Current report
Oct 03, 2023

Major Issues Report

Form 8-K - Current report
Sep 27, 2023

Major Issues Report

Form 8-K - Current report
Jul 31, 2023

Major Issues Report

Form 8-K - Current report
Jul 31, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 29, 2023

Major Issues Report

Form 8-K - Current report
May 31, 2023

Major Issues Report

Form 8-K - Current report
May 12, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 12, 2023

Major Issues Report

Form 8-K - Current report
Oct 04, 2022

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Oct 03, 2022

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Oct 03, 2022

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Oct 03, 2022

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Oct 03, 2022

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Oct 03, 2022

Major Issues Report

8-K - Current report
Sep 29, 2022

Major Issues Report

8-K - Current report
Sep 27, 2022

Major Issues Report

8-K - Current report
Sep 23, 2022

Major Issues Report

8-K - Current report
Sep 23, 2022

Major Issues Report

8-K - Current report